Today’s AI Top Pick: MORN
7/23/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live MORN price forecast →
Morningstar (MORN) is the cleanest setup in this pool: it's the only name that combines top-decile fundamentals with genuine multi-timeframe agreement and supportive news flow. Fundamentally, MORN screens as a quality compounder trading at a discount — PE 17 / fwdPe 12.4 / PEG 0.71, ROE 30.66%, profit margin 16.06%, sales growth +8.39% YoY, recom 1.67, targetUpsidePct 35.5%, and a fundamental_score of 8 (the joint-highest here alongside TOYO, which is disqualified by a recent $50M raise). The stock is off -39.78% over the year and -23.23% YTD, so the reset has already happened. The tape confirms the turn across horizons. 4h forecasts are +6.08/+6.32/+13.55 with recent 21-bar change +7.1%; 1d forecasts are +17.48/+21.57/+24.68 with recent +9.21% and drawdown just -4.07%; the 1wk shows the biggest asymmetry — recent -11.74% but forecasts +17.56/+39.09/+49.88, i.e., the weekly is coiled at the bottom of its range (pos 38.03%, dd -11.74%) while daily/4h have already flipped up. bullish_prob = 1.0 and near_term_bullish = 1.0. The only yellow flag is the 1h fc_short at -3.04%, which is a feature, not a bug — it says today's intraday dip IS the entry. Position-in-range is the one nuance: 1d is at 78% and 4h at 71%, so the daily has already moved. But drawdowns are shallow (-2.9% to -4.07%), the weekly is still mid-range, and the fundamentals justify paying up here versus chasing extended microcaps like TASK (95% of 1d range, 97% of 4h range) or waiting for broken names like BESS/HCWB/IPWR that need a turnaround AND have dilution or reverse-split overhangs. News is a tiebreaker in MORN's favor: 7/22 launch of the US Capital Allocation Leaders Index, Global X adopting a new Morningstar Index, and PitchBook winning Best Alternative Data Provider — all recurring-revenue-friendly, no dilution, no legal/regulatory issues. Compare that to IPWR (fresh $75M shelf), TOYO (~$50M raise + CFO change), HCWB (1-for-6 reverse split), PRSO ($25M ATM), MBRX (interim data missed significance -25%), and CCB (CFO transition). MORN is the one name where forecast, fundamentals, AND newsflow all point the same direction today.
- Debt/Equity 1.87 is elevated for a services/data firm — rate sensitivity if macro tightens further
- 1d position_in_range at 78.24% means today's entry is not deep in the base; a 3-5% pullback to 1h fc_short (-3.04%) is a real risk before the run
- Perf YTD -23.23% and PerfYear -39.78% — the trend has been sharply negative and needs a genuine reversal, not just a bounce
- $6.34B market cap means low-float dynamics won't produce microcap-style pops; upside is more measured (35.5% analyst target)
- Weekly recent -11.74% means the higher-timeframe structure is still repairing; a broader market pullback could re-test $155
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | MORN | BUY NOW | 8.6 | Quality compounder at PEG 0.71 with all timeframes 4h+ pointing up, +35.5% analyst upside, and positive index-launch newsflow. |
| 2 | HURN | BUY NOW | 7.6 | Recom 1.00, fwdPe 10.92, +65% analyst upside, 1d fc_long +33% — but weekly still bearish so size accordingly. |
| 3 | USLM | BUY NOW | 6.8 | High-margin materials name with near_term_bullish 1.0 and clean fundamentals, but capped ~21% upside and weekly fc negative. |
| 4 | AZO | BUY PULLBACK | 6.2 | Blue-chip retailer with 1d fc_long +24.9% and near_term_bullish 1.0; weekly forecasts are negative and it's not really 'low float' in spirit. |
| 5 | TASK | BUY PULLBACK | 5.6 | PE 5.15, fwdPe 3.8, ROE 26.5%, 1d fc +40% — but pos_in_range at 90-97% across intraday and recom 2.86 says chase risk. |
| 6 | SHOE | BUY NOW | 5.2 | PE 10.88, fwdPe 7.99, 1wk fc_long +78%, pos 5-28%, but recom 2.33 and short float 21% add friction. |
| 7 | IDN | BUY PULLBACK | 5.0 | 1d fc +34-50% and pos 0%, but 1wk fc_long has flipped to -3.48% and weekly recent -23.3% — trend deteriorating on higher TF. |
| 8 | BESS | BUY PULLBACK | 4.8 | Weekly fc +60/72/104% is huge, but -70% YTD, no revenue visibility, and 39% drawdown says catch-a-knife risk. |
| 9 | CCB | WAIT | 4.7 | Bank with 1d fc_mid +43.85% but bullish_prob null, CFO transition just announced, and weekly fc turns negative. |
| 10 | NXTC | WAIT | 4.6 | Reverse-merger into Avere with $320M PIPE and CVR — thesis has completely changed; recent +148% already priced the news. |
| 11 | MBRX | AVOID | 4.4 | 1d fc +42-226% looks huge but MIRACLE trial interim data missed significance (-25% on that news); short float 26.72%. |
| 12 | EVGN | BUY PULLBACK | 4.4 | Positive deal news with ELEO for PCSK9; 1d fc +91-109% and near_term_bullish 1.0, but sales -72.7% and profitMargin -638%. |
| 13 | QNTM | BUY PULLBACK | 4.2 | Weekly fc +14/+337/+1116% and 1d fc +93-105% with near_term_bullish 1.0, but ROE -984% and no revenue. |
| 14 | BCDA | BUY PULLBACK | 4.1 | 1wk fc +130-158% and near_term_bullish 1.0 but sales -100% and no fundamentals to lean on. |
| 15 | XTLB | WAIT | 4.0 | 1wk fc +67/82/107% but 1h fc negative (-13 to -15%) and pos at 100% — extended into resistance. |
| 16 | DRMA | WAIT | 3.8 | 1wk fc numbers are effectively unusable (+26,000%) — data quality issue; ignore signal. |
| 17 | GLMD | BUY PULLBACK | 3.7 | New cardiac lipid nanoparticle formulation is a real catalyst; 1d fc +56-122% but sub-$0.50 penny with 4M mcap. |
| 18 | CRVO | BUY PULLBACK | 3.6 | HC Wainwright $25 PT and positive AAIC data; but recent 21-bar -64.81% and near_term_bullish only 0.4 wasn't provided (defaulting cautious). |
| 19 | INTZ | WAIT | 3.5 | 1h fc negative and 1d recent +19% already faded; investor day upcoming but stock sinking day-to-day. |
| 20 | HCWB | AVOID | 3.3 | Just did 1-for-6 reverse split to regain Nasdaq compliance — structural overhang trumps the +641% weekly fc. |
| 21 | CALC | AVOID | 3.3 | $49M PIPE announced 6/24 caps upside; -88.7% YTD; 1d fc +234% is single-bar outlier not to be trusted. |
| 22 | GRCE | WAIT | 3.2 | 1d fc +44% and recom 1.00 but weekly recent -38.6% and drawdown -53.8% — broken trend. |
| 23 | LTRN | WAIT | 3.1 | ZetaOmics launch is neat but weekly recent barely +5%, 1d recent -28% — no momentum confirmation. |
| 24 | LUCY | AVOID | 3.0 | Recent warrant exercise for $3M is dilution; recom 3 (hold); operMargin -300%. |
| 25 | PRSO | AVOID | 2.9 | $25M equity line with Roth on 7/2 = active dilution overhang overrides any forecast. |
| 26 | HSCS | AVOID | 2.7 | 1h/4h forecasts negative; profitMargin -97,880% (nano-cap accounting artifact) — untradeable. |
| 27 | USBC | AVOID | 2.6 | Weekly fc +1,220-2,115% is unrealistic; 1d fc actually negative -43.74%; bullish_prob 0.6. |
| 28 | IPWR | AVOID | 2.4 | Filed $75M shelf on 7/10 — pure dilution setup; PS 2,244 tells you fundamentals are broken. |
| 29 | TOYO | AVOID | 2.3 | Just raised ~$50M at $11 and expected_return_pct is -12.6%; near_term_bullish only 0.4. |
| 30 | AMR | AVOID | 2.2 | Symbol collision with AMR Resources Acquisition IPO news; Alpha Met has UBS Neutral, recom 2.83, operMargin -1.49%. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord